Mariko Tomita

Dr. Mariko Tomita, molecular oncologist, graduated from Medical School, Kyushu University, Fukuoka, Japan in 1992. She worked for Kyushu University Hospital as an intern in 1992/1993. She earned a Ph.D. in molecular oncology from Kyushu University in 1998. She spent 3 years at IGBMC (Strasbourg, France) and Free University (Amsterdam, The Netherlands) and performed post-doctoral research. Then, she moved to the University of the Ryukyus, Okinawa, Japan and started the research in viral oncology. She is presently an Associate Professor at the Department of Pathology and Oncology.

1books edited

2chapters authored

Latest work with IntechOpen by Mariko Tomita

T-cell leukemia is relatively rare malignancy of thymocytes. There are around 20 entities and variants of this disease. Each of them has different characteristics, including pathogenesis, epidemiology, diagnosis, therapeutic approaches, and prognosis. Although T-cell leukemia is relatively rare malignancy, many types of T-cell leukemias still have a very poor prognosis due to rapid progression. Therefore, the development of novel therapeutic and preventive strategies is necessary to improve prognosis. The purpose of this book is to provide a comprehensive overview of the disease from the basics of pathogenesis, epidemiology, morphology, and immunological features. This book also highlights the most recent achievements from basic and clinical researches including molecular mechanisms and novel therapies of T-cell leukemia.

Go to the book